DARICON Drug Patent Profile
✉ Email this page to a colleague
When do Daricon patents expire, and what generic alternatives are available?
Daricon is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in DARICON is oxyphencyclimine hydrochloride. Additional details are available on the oxyphencyclimine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DARICON?
- What are the global sales for DARICON?
- What is Average Wholesale Price for DARICON?
Summary for DARICON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 46 |
| Patent Applications: | 96 |
| DailyMed Link: | DARICON at DailyMed |
US Patents and Regulatory Information for DARICON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | DARICON | oxyphencyclimine hydrochloride | TABLET;ORAL | 011612-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
